Literature DB >> 17707590

Inhibition of L-selectin binding by polyacrylamide-based conjugates under defined flow conditions.

Sven Enders1, Gesche Bernhard, Andreas Zakrzewicz, Rudolf Tauber.   

Abstract

Selectins mediate tethering and rolling of leukocytes along the endothelium in a shear force-dependent manner. This key step in the cellular immune response is a target for experimental anti-inflammatory therapies. In the present paper we have examined the inhibitory activity of the minimal selectin ligand sialyl Lewis x (SiaLe(x)), its isomer sialyl Lewis a (SiaLe(a)) and sulfated tyrosine (sTyr) residues under dynamic flow reflecting the rheological conditions in the blood stream. The monomeric ligands were compared to multivalent polyacrylamide (PAA)-based conjugates under defined flow conditions on the molecular level, using surface plasmon resonance (SPR) technology, and on the cellular level, using a parallel-plate flow chamber. SPR measurements showed that a spatial arrangement of binding epitopes mimicking the selectin binding motif of the natural ligand PSGL-1 inhibits L-selectin binding successfully with IC(50) values in the nanomolar range. Using a flow chamber adhesion assay it could be shown that the multivalent inhibitors efficiently blocked rolling and tethering of NALM-6 pre-B cells transfected with human L-selectin to activated endothelium and that the inhibitory activity increased with rising shear stress. While PAA-conjugates were almost not inhibitory at low shear stress, NALM-6 cell rolling was nearly completely inhibited at high shear stress. The results indicate that multimeric conjugates of SiaLe(x), SiaLe(a) and sTyr are highly effective inhibitors of L-selectin-mediated cell adhesion particularly under flow conditions. Consequently, SiaLe(x), SiaLe(a) and/or sTyr on macromolecular carriers may be promising candidates for anti-inflammatory therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707590     DOI: 10.1016/j.bbagen.2007.06.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation.

Authors:  Jens Dernedde; Alexandra Rausch; Marie Weinhart; Sven Enders; Rudolf Tauber; Kai Licha; Michael Schirner; Ulrich Zügel; Arne von Bonin; Rainer Haag
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

2.  Generation of shear adhesion map using SynVivo synthetic microvascular networks.

Authors:  Ashley M Smith; Balabhaskar Prabhakarpandian; Kapil Pant
Journal:  J Vis Exp       Date:  2014-05-25       Impact factor: 1.355

3.  Rapid assembly of oligosaccharides: a highly convergent strategy for the assembly of a glycosylated amino acid derived from PSGL-1.

Authors:  Yusuf Vohra; Therese Buskas; Geert-Jan Boons
Journal:  J Org Chem       Date:  2009-08-21       Impact factor: 4.354

4.  Architecture effects on L-selectin shedding induced by polypeptide-based multivalent ligands.

Authors:  Shuang Liu; Kristi Kiick
Journal:  Polym Chem       Date:  2011-07       Impact factor: 5.582

5.  Synthesis of multivalent carbohydrate mimetics with aminopolyol end groups and their evaluation as L-selectin inhibitors.

Authors:  Joana Salta; Jens Dernedde; Hans-Ulrich Reissig
Journal:  Beilstein J Org Chem       Date:  2015-05-05       Impact factor: 2.883

6.  Chemoenzymatic synthesis of functional sialyl Lewis(x) mimetics with a heteroaromatic core.

Authors:  Claudine Schlemmer; Christine Wiebe; Dorota Ferenc; Danuta Kowalczyk; Stefanie Wedepohl; Patrick Ziegelmüller; Jens Dernedde; Till Opatz
Journal:  Chem Asian J       Date:  2014-05-30

7.  Polyglycerolsulfate functionalized gold nanorods as optoacoustic signal nanoamplifiers for in vivo bioimaging of rheumatoid arthritis.

Authors:  Jonathan Vonnemann; Nicolas Beziere; Christoph Böttcher; Sebastian B Riese; Christian Kuehne; Jens Dernedde; Kai Licha; Claudio von Schacky; Yvonne Kosanke; Melanie Kimm; Reinhard Meier; Vasilis Ntziachristos; Rainer Haag
Journal:  Theranostics       Date:  2014-03-20       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.